Appendix 3B — Renounceable Rights Issue

Mar 25, 2020
Posted in: Investor updates

Home » Appendix 3B — Renounceable Rights Issue

Appendix 3B — Renounceable Rights Issue

Mar 25, 2020
Posted in: Investor updates

Imagion Biosystems Limited has released Appendix 3B — Renounceable Rights Issue. Read Appendix 3B.

Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December

December 2, 2025

Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December Key Highlights: MagSense® HER2

The Market Bull Podcast – Imagion Biosystems and the Future of MRI

November 25, 2025

The Market Bull recently invited Imagion Biosystems’ Ward Detwiler and Wayne State University’s Dr. Mark Haacke on the podcast to discuss how molecular MRI and

Join Us at RSNA and SABCS: Advancing Molecular MRI for Cancer Detection

November 13, 2025

We are excited to announce that Imagion Biosystems (ASX: IBX) will be attending two premier medical conferences this fall: the Radiological Society of North

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

Appendix 3B — Renounceable Rights Issue

Appendix 3B — Renounceable Rights Issue

Related Articles

Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December

The Market Bull Podcast – Imagion Biosystems and the Future of MRI

Join Us at RSNA and SABCS: Advancing Molecular MRI for Cancer Detection

Transforming medical imaging for early disease detection

About Imagion Biosystems

Contact us

Join our email list